Taiwan · Delayed Price · Currency is TWD Shine-On BioMedical Statistics
Total Valuation
TPEX:6926 has a market cap or net worth of TWD 3.16 billion. The enterprise value is 2.35 billion.
| Market Cap | 3.16B |
| Enterprise Value | 2.35B |
Important Dates
The next estimated earnings date is Thursday, August 20, 2026.
| Earnings Date | Aug 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6926 has 49.80 million shares outstanding. The number of shares has increased by 0.63% in one year.
| Current Share Class | 49.80M |
| Shares Outstanding | 49.80M |
| Shares Change (YoY) | +0.63% |
| Shares Change (QoQ) | +0.41% |
| Owned by Insiders (%) | 4.55% |
| Owned by Institutions (%) | n/a |
| Float | 22.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 62.48 |
| PB Ratio | 4.00 |
| P/TBV Ratio | 4.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 46.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.17
| Current Ratio | 14.17 |
| Quick Ratio | 13.76 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10,312.21 |
Financial Efficiency
Return on equity (ROE) is -20.60% and return on invested capital (ROIC) is -13.87%.
| Return on Equity (ROE) | -20.60% |
| Return on Assets (ROA) | -13.37% |
| Return on Invested Capital (ROIC) | -13.87% |
| Return on Capital Employed (ROCE) | -24.76% |
| Weighted Average Cost of Capital (WACC) | 3.52% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 22 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TPEX:6926 has paid 23,000 in taxes.
| Income Tax | 23,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.57% in the last 52 weeks. The beta is -0.13, so TPEX:6926's price volatility has been lower than the market average.
| Beta (5Y) | -0.13 |
| 52-Week Price Change | -7.57% |
| 50-Day Moving Average | 63.65 |
| 200-Day Moving Average | 67.10 |
| Relative Strength Index (RSI) | 50.33 |
| Average Volume (20 Days) | 6,290 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6926 had revenue of TWD 50.62 million and -181.72 million in losses. Loss per share was -3.63.
| Revenue | 50.62M |
| Gross Profit | 50.62M |
| Operating Income | -195.93M |
| Pretax Income | -181.69M |
| Net Income | -181.72M |
| EBITDA | -193.80M |
| EBIT | -195.93M |
| Loss Per Share | -3.63 |
Balance Sheet
The company has 808.81 million in cash and no debt, with a net cash position of 808.81 million or 16.24 per share.
| Cash & Cash Equivalents | 808.81M |
| Total Debt | n/a |
| Net Cash | 808.81M |
| Net Cash Per Share | 16.24 |
| Equity (Book Value) | 791.21M |
| Book Value Per Share | 15.88 |
| Working Capital | 776.42M |
Cash Flow
In the last 12 months, operating cash flow was -143.38 million and capital expenditures -41,000, giving a free cash flow of -143.42 million.
| Operating Cash Flow | -143.38M |
| Capital Expenditures | -41,000 |
| Depreciation & Amortization | 2.14M |
| Net Borrowing | -1.32M |
| Free Cash Flow | -143.42M |
| FCF Per Share | -2.88 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -387.09% |
| Pretax Margin | -358.95% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPEX:6926 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.63% |
| Shareholder Yield | -0.63% |
| Earnings Yield | -5.75% |
| FCF Yield | -4.54% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |